The conventional story about Scott Kelly’s year in space is that he came back taller, weaker, and a few milliseconds younger than his identical twin Mark. That is the version that fits in a headline. The version NASA actually published is stranger and harder to summarize. Roughly seven percent of Scott Kelly’s gene expression had not returned to its preflight baseline six months after he landed. His telomeres, the protective caps on his chromosomes, had grown longer in orbit and then collapsed below pre-mission length once he was back on Earth. His cognitive performance was measurably slower for years afterward. The popular framing — that space changed his DNA — is approximately right in its emotional effect and badly incomplete in its mechanics.
Most coverage of the twin study treated it as a curiosity, a one-off oddity about a single astronaut. That framing misses the point. Scott and Mark Kelly are identical twin astronauts, which means they are a matched control pair for studying what spaceflight does to a human body at the molecular level. The findings are not about Scott Kelly. They are about what happens to anyone who spends a year above the atmosphere.
The experiment that could only be run once
Scott Kelly boarded a Soyuz capsule bound for the International Space Station for a 340-day stay. Mark Kelly, a retired astronaut himself, remained on the ground in Arizona. The two men shared the same genome, the same upbringing, and most of the same lifetime environmental exposures. For the duration of the mission, NASA collected blood, urine, saliva, stool, and cognitive performance data from both brothers on nearly identical schedules.
That sentence sounds like a science-fair setup. It is, in fact, the closest thing modern biology has produced to a controlled experiment on a human being in extreme environment exposure. Genetically identical subjects, one variable changed — orbital velocity, cosmic radiation, and continuous microgravity — and a multi-year longitudinal dataset on both sides. The mission ended after 340 days. The full paper took three more years to assemble.
What the data actually said
The headline finding, picked up briefly and then garbled badly in the popular press, was that Scott Kelly’s gene expression had changed. The garbled version was that his DNA was now seven percent different from his brother’s. That claim is false. The genome itself — the sequence of base pairs — does not rearrange itself in a year of spaceflight, and Scott Kelly remains genetically identical to Mark in the strict sense.
What did change was gene expression: which genes were switched on, which were switched off, and how loudly each was being read by the cellular machinery. Most of Scott Kelly’s expression patterns returned to baseline within six months of landing. Approximately seven percent did not. The genes that remained dysregulated were concentrated in immune function, DNA repair, bone formation, hypoxia response, and mitochondrial activity. In other words, the cellular systems most stressed by radiation and microgravity were the ones that stayed altered the longest.
This matters because mitochondrial dysfunction has since emerged as a recurring signature across multiple astronaut datasets. Defects in mitochondria appear to underlie a surprising range of the physiological changes astronauts report on return, from immune suppression to muscle atrophy to the persistent fatigue that even short-duration crews describe. The twin study did not prove the mechanism. It pointed at it, hard.

The telomere result nobody expected
Telomeres are the repetitive DNA sequences that cap the ends of chromosomes. They shorten with every cell division, with chronic stress, with poor sleep, and with age. They are one of the most reliable molecular proxies for biological aging that researchers have. Every prediction going into the twin study said Scott Kelly’s telomeres would be shorter when he came home, because spaceflight is, by every available measure, a high-stress environment.
They were longer. Substantially longer, on average, throughout the mission. The result was so unexpected that the research team initially suspected a sample-handling error and re-ran the assays. The lengthening was real.
And then, within forty-eight hours of landing, his telomeres collapsed. Not back to baseline, but below it. He returned from orbit with a population of unusually short telomeres and a measurable increase in chromosomal aberrations that persisted for years. The most plausible interpretation is that microgravity altered the cell-division dynamics of his hematopoietic stem cells in orbit, and the return to gravity, fluid redistribution, and Earth-normal physiology triggered a wave of accelerated cellular aging on the ground. Subsequent work at UC San Diego’s Sanford Stem Cell Institute has found that spaceflight accelerates the aging of human hematopoietic stem and progenitor cells in ways consistent with what the Kelly data hinted at.
The cognitive penalty
The part of the study that received the least public attention may be the most consequential for any future Mars mission. Scott Kelly’s reaction times, accuracy, and risk-taking calibration all degraded during the final months in orbit, which was expected. What was not expected was that his cognitive performance remained measurably slower than his preflight baseline for months of post-mission testing. He had not recovered. Whether he ever fully did is a question the published study does not answer.
This finding aligns with what researchers studying long-duration crews have reported elsewhere. Long-duration spaceflight appears to leave cognitive fingerprints that outlast the obvious physical recovery period. The brain, like the immune system, does not snap back the way muscle and bone eventually do.
Why the liver, of all things, matters
One of the quieter findings in the twin dataset, and one that has gained traction since 2019, involves metabolic regulation. Scott Kelly’s lipid profile, insulin sensitivity, and markers of liver function all shifted in orbit and were slow to normalize. The liver is not the organ most people associate with spaceflight risk, but it is the organ that integrates nearly every metabolic signal in the body, and microgravity exposure appears to alter hepatic metabolism in ways researchers are still mapping. If the liver’s regulatory functions drift during long-duration flight, almost every downstream system drifts with it.
This is the part of the story worth slowing down on. The popular framing of astronaut health treats the body as a collection of separable problems: bone loss here, radiation exposure there, immune suppression somewhere else. The twin study, read carefully, suggests something different. The systems are coupled. Mitochondrial dysfunction feeds immune dysregulation, which alters gene expression, which changes how the liver processes lipids, which feeds back into cellular energy production. Spaceflight does not break one thing. It perturbs a network.

The radiation problem nobody has solved
Scott Kelly absorbed ionizing radiation during his time on the ISS, which sits within the relative protection of Earth’s magnetosphere. A Mars crew operating beyond that protection would absorb several times more, including periodic exposure to solar particle events that can deliver a year’s worth of dose in hours. The radiation environment beyond low Earth orbit is qualitatively different from the ISS environment, and the engineering solutions remain incomplete. Even the ten-day Artemis II lunar mission required new dosimetry hardware to track crew exposure in real time, because the modeling alone is no longer considered adequate.
The twin study did not isolate radiation as the cause of any specific finding. The mission environment combined microgravity, radiation, sleep disruption, dietary restriction, social isolation, and chronic low-grade hypercapnia from the station’s elevated carbon dioxide levels. Untangling which exposure produced which molecular signature is a problem that may require dozens more long-duration crew members studied at the same depth, and they will not be identical twins.
Records that keep getting broken
Scott Kelly’s 340-day mission was the American single-flight record until Frank Rubio surpassed it with a 371-day stay that ended in 2023, after his planned six-month rotation was extended by a Soyuz coolant leak. Christina Koch set the women’s record at 328 days in 2020 and is now slated to become the first woman to orbit the Moon as part of Artemis II. Each long-duration crew adds another data point to what the twin study began, but none of them have a genetic doppelganger on the ground to compare against.
That is the unrepeatable part of what happened. The twins were a coincidence of biography — two brothers who both became astronauts, one of whom volunteered for a year-long mission while the other was available to serve as the control. NASA will not get another matched pair. Whatever the next two decades of long-duration flight reveal about the molecular cost of leaving the planet, it will be revealed against the baseline that Scott and Mark Kelly happened to provide.
What the seven percent actually means
Six years after the twin study was published, the cleanest summary remains the one the researchers themselves offered: human physiology is more plastic, more reactive, and less reversible under spaceflight conditions than the pre-mission models predicted. Most of what changed in Scott Kelly came back. A measurable fraction did not. The fraction that did not is concentrated in exactly the systems — immune, mitochondrial, cognitive, telomeric — that any Mars mission would need to function reliably for two to three years without resupply.
The body remembers orbit. Not metaphorically, and not in the way the headlines suggested. It remembers in the form of gene-expression patterns that never fully reset, telomere distributions that never fully recover, and cognitive baselines that may have permanently shifted. Scott Kelly came back to Earth a slightly different man, in a literal molecular sense, than the one who left. The species has not yet decided whether the trade is acceptable for the next destination.